What Is IGF-1 LR3?
IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is an 83-amino acid synthetic analog of native IGF-1, engineered with two specific modifications — an arginine substitution at position 3 and a 13-amino acid N-terminal extension — that reduce its binding to insulin-like growth factor binding proteins (IGFBPs) by approximately 1000-fold. The result is a research compound with an effective half-life of approximately 20–30 hours compared to native IGF-1's 12–15 minutes, making IGF-1 LR3 the standard tool for studying IGF-1 receptor signaling in cell culture and in vivo models where rapid clearance would otherwise confound results.
By: Palmetto Peptides Research Team | Date: March 11, 2026
For research purposes only. Not intended for human or veterinary use. Not for human consumption.
How Do the LR3 Modifications Change IGF-1's Pharmacokinetics?
The two structural modifications in IGF-1 LR3 address the central pharmacokinetic limitation of native IGF-1 — its near-immediate sequestration by IGFBPs 1–6, present in high concentrations in both serum and tissue interstitium.
Modification 1 — Arginine substitution at position 3 (R3):
Native IGF-1 has glutamic acid (Glu) at position 3. Substituting arginine (Arg) changes the charge environment at the N-terminal region, significantly disrupting the binding interface for IGFBPs 1, 2, and 3 — the primary binding proteins that sequester native IGF-1.
Modification 2 — 13-amino acid N-terminal extension:
A 13-residue extension (Met-Ala-Glu-Ala-Pro-Ala-Glu-Ala-Ser-Gly-Gly-Gly-Pro) is added to the N-terminus, providing additional steric interference with IGFBP binding while leaving the C-domain receptor binding region (which engages IGF-1R) structurally intact.
Together, these modifications reduce IGFBP binding affinity by ~1000-fold compared to native IGF-1, allowing IGF-1 LR3 to circulate in free, bioavailable form for 20–30 hours rather than minutes.
What Signaling Pathway Does IGF-1 LR3 Activate?
IGF-1 LR3 binds the IGF-1 receptor (IGF-1R), a transmembrane receptor tyrosine kinase (RTK) encoded by the IGF1R gene on chromosome 15q26.3. Upon binding, IGF-1R undergoes transphosphorylation at tyrosine residues Y1135/Y1136 (activation loop), initiating the canonical anabolic signaling cascade:
IGF-1R → IRS-1/IRS-2 phosphorylation → PI3K activation → PIP₃ → Akt (PKB) activation → mTORC1 signaling
This PI3K/Akt/mTOR axis is associated with:
- Cell survival and anti-apoptotic signaling (Akt phosphorylation of BAD, FOXO transcription factors)
- Protein synthesis initiation (mTORC1 → S6K1 and 4EBP1 phosphorylation)
- Cell cycle progression (cyclin D1 upregulation, CDK4 activation)
- Glucose uptake (GLUT4 translocation in muscle cell models)
IGF-1R also signals through the MAPK/ERK pathway (Ras → Raf → MEK → ERK1/2), associated with cell proliferation and differentiation responses.
What Research Applications Is IGF-1 LR3 Used For?
IGF-1 LR3 is primarily a cell biology and molecular research tool, valued for maintaining sustained IGF-1R activation without the constant media supplementation required for native IGF-1.
Skeletal muscle cell research: In primary myoblast and satellite cell culture models, IGF-1 LR3 is used to study myogenic differentiation, myotube formation, and anabolic signaling. Satellite cells (muscle stem cells, marked by PAX7 expression) respond to IGF-1R activation with proliferative expansion and subsequent differentiation — a research model for studying muscle regeneration biology.
Cell proliferation and survival models: Used in cancer biology research to study IGF-1R-mediated survival signaling in tumor cell lines, where the PI3K/Akt pathway is frequently dysregulated.
In vitro advantage: Cell culture media contains IGFBP-secreting cells that would rapidly sequester native IGF-1. IGF-1 LR3's reduced IGFBP binding allows it to be added once at experiment start and maintain active IGF-1R engagement throughout a typical 12–72 hour experimental window.
How Does IGF-1 LR3 Differ from Native IGF-1 and Growth Hormone?
| Compound | Receptor | Half-Life | IGFBP Binding | Primary Research Use |
|---|---|---|---|---|
| Native GH | GHR | ~15–30 min | N/A | Upstream GH axis signaling |
| Native IGF-1 | IGF-1R | ~12–15 min (free) | High (~99% bound) | Endogenous IGF-1R baseline |
| IGF-1 LR3 | IGF-1R | ~20–30 hours | ~1000x reduced | Sustained IGF-1R research without IGFBP interference |
Frequently Asked Questions
Q: What are IGFBPs and why do they matter for IGF-1 research?
A: IGFBPs (1–6) are carrier proteins that bind IGF-1 in circulation and tissue. Under normal conditions, ~99% of circulating IGF-1 is IGFBP-bound and cannot activate IGF-1R. Native IGF-1's short effective half-life in research settings is primarily a function of this IGFBP sequestration.
Q: Why is a 20–30 hour half-life experimentally significant?
A: It spans the typical in vitro experimental window (12–72 hours). Native IGF-1 in serum-containing media would need replenishment every hour to maintain a sustained signal. IGF-1 LR3 added once at experiment start maintains active IGF-1R engagement throughout, dramatically simplifying experimental design.
Q: Does IGF-1 LR3 bind the insulin receptor (IR)?
A: IGF-1 LR3 has some cross-reactivity with the insulin receptor, as IGF-1R and IR share structural homology. This cross-reactivity is lower than native IGF-1, but researchers working with insulin-sensitive cell lines should account for potential IR co-activation at higher concentrations.
Q: What is the mTOR pathway and why is it relevant?
A: mTORC1 is activated downstream of Akt and phosphorylates S6K1 and 4EBP1 — key regulators of ribosome biogenesis and mRNA translation initiation. IGF-1 LR3's ability to sustain PI3K/Akt/mTORC1 activation makes it a key tool in mTOR pathway research in muscle cell, cancer cell, and metabolic biology models.
Q: Is IGF-1 LR3 the same as mechano growth factor (MGF)?
A: No. MGF (IGF-1Ec) is a splice variant of the IGF1 gene produced locally in muscle in response to mechanical loading. IGF-1 LR3 is a synthetic analog of the mainstream liver-produced IGF-1 isoform (IGF-1Ea), not of MGF.
Explore Palmetto Peptides Research Compounds
All products are research-grade, COA verified, and intended for laboratory research use only.